3Sumiyoshi T,Gotoda T,Muro K,et al.Morbidity and mortality afterself-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy.Gastrointest Endosc,2003,57:882-885.
4Lam YH,Chan A,Lan J,et al.Self-expandable metal stents for malignant dysphagia.Aust N Z J Surg,1999,69:668-671.
二级参考文献6
1Vikram B, Hilaris BS, Anderson L, et al. Permanent^125 Iodineimplants in head and neck cancer. Cancer, 1983,51:1310-1314.
2Martinez-Monge R, Nag S, Martin EW.^125 Iodine brachytherapy for colorectal adenocarcinoma recurrent in the pelvis and paraortics. Int J Radiot Oncol biol Phys, 1998,42:545-550.
3Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent ^125Iodine implantation for early-stage prostatic cancer. J Clin Oncol, 1999,17:517-522.
4Battermann JJ.^125Iodine implantation for localized prostate cancer, the Utrecht University experience. Radiother Oncol,2000,57:269-272.
